The positive correlation between DLL3 and ASCL1 expressions further underscores their interconnected roles in SCLC’s molecular landscape, suggesting that interventions targeting these pathways could offer new avenues for treatment [15]. This evidence concerns the gene DLL3 and small cell lung carcinoma.